NCT05997316

Brief Summary

Obesity and related metabolic comorbidities have been associated with more than a 4-fold increased risk of incident cognitive impairment, including Alzheimer's disease and related dementias (ADRD). Dysfunctional metabolic flexibility is increasingly recognized as a critical mechanism linking metabolic risk factors to risk of cognitive impairment, although few studies portable behavioral strategies to enhance metabolic function among individuals at risk for ADRD. The present study will examine the feasibility and acceptability of a 12-week time restricted feeding intervention among individuals with mild cognitive impairment (MCI). Changes in cognitive and metabolic function will also be examined.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 7, 2023

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

August 10, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 18, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 26, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 26, 2025

Completed
9 months until next milestone

Results Posted

Study results publicly available

March 27, 2026

Completed
Last Updated

March 27, 2026

Status Verified

August 1, 2025

Enrollment Period

1.9 years

First QC Date

August 10, 2023

Results QC Date

January 26, 2026

Last Update Submit

March 6, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Memory Composite Rank

    Participants completed two assessments of learning and memory at each time point. The Hopkins Verbal Learning Test Revised (HVLT-R) was used to assess verbal memory and the Brief Visual Memory Test - Revised (BVMT-R) was used to assess visual memory. Both the HVLT-R and the BVMT-R provide three separate scores that reflect total learning, retention of information, and recognition of learned items following a delay. In order to create a single Memory performance score, each of these six scores were ranked at each time point and a mean rank was created, with higher scores reflecting higher Memory performance. The mean rank for Memory performance at 12 weeks was used as the outcome, controlling for baseline Memory performance. If time restricted fasting was effective in improving Memory performance, then the mean rank composite score should be larger at 12 weeks compared to baseline.

    Baseline, 12 Weeks

  • Change in Executive Function Composite Rank

    Participants underwent multiple assessments of Executive Functioning at each time point. Specifically, participants completed the Trail Making Test Parts A \& B, the Digit Span Forwards and Backwards Tasks, the Digit Symbol Substitution Test, the Controlled Oral Word Association Test, the Animal Naming Test, and the Stroop Word and Color-Word Interference Tests at both pre-and-post treatment. In order to create a single Executive Function score, each of these nine measures were ranked at each time point and a mean rank was created, with higher scores reflecting higher Executive Function performance. The mean rank for Executive Function performance at 12 weeks was used as the outcome, controlling for baseline Executive Function performance. If time restricted fasting was effective in improving Executive Function performance, then the mean rank composite score should be larger at 12 weeks compared to baseline.

    Baseline, 12 Weeks

Secondary Outcomes (2)

  • Change in Metabolic Function Composite Rank

    Baseline, 12 Weeks

  • Change in Inflammatory Function Composite Rank

    Baseline, 12 Weeks

Study Arms (1)

Time restricted eating

EXPERIMENTAL

Participants will engage in a 12-week time restricted fasting intervention. Each week, participants will work with a clinical psychologist to modify the timing of their eating behaviors to adhere to a 16-hour fast, 2-3 days per week.

Behavioral: Time restricted eating

Interventions

Participants will work with a psychologist towards achieving a 16 hour fasting period, 2-3 days per week. The intervention will last 12 weeks, with different intervention materials gradually introduced over the course of the 12 weeks.

Time restricted eating

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Subjects will include those men and women:
  • aged 65-80 years,
  • with amnestic Mild Cognitive Impairment (Montreal Cognitive Assessment Battery score \[MoCA\] total score 19-25 or a phonemic fluency score of =\<12 (with MoCA \>25) or semantic fluency score of =\<15 (with MoCA \>15); and score of \> 1.0 on the Mail-in Cognitive Function Screening Instrument),
  • obese (body mass index 27.5-40 kg/m\^2),
  • sedentary, and
  • willing to participate in all aspects of the proposed intervention.

You may not qualify if:

  • secondary causes of obesity,
  • evidence of clinical dementia (MoCA score \< 18), severe chronic kidney disease (eGFR \<45 ml/min/1.73m\^2),
  • heart failure,
  • high grade arrhythmias,
  • severe valvular heart disease,
  • severe asthma or chronic obstructive lung disease,
  • diabetes requiring insulin,
  • musculoskeletal or neurologic problems that would preclude participation in aerobic exercise training,
  • a major psychiatric disorder,
  • a history of drug abuse,
  • alcohol consumption \>14 drinks/week,
  • gastric bypass surgery,
  • non-English speaking, or
  • a life-limiting comorbid medical condition (e.g. cancer).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina

Chapel Hill, North Carolina, 27519, United States

Location

MeSH Terms

Conditions

Cognitive DysfunctionObesity

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Patrick J. Smith, PhD, MPH
Organization
University of North Carolina at Chapel Hill

Study Officials

  • Patrick J Smith, PhD, MPH

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Assessors will be blinded to the participant's intervention fidelity and engagement.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2023

First Posted

August 18, 2023

Study Start

August 7, 2023

Primary Completion

June 26, 2025

Study Completion

June 26, 2025

Last Updated

March 27, 2026

Results First Posted

March 27, 2026

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

We will submit de-identified study data to a public database in accordance with the NIH data sharing policy. Datasets will be prepared and submitted to the appropriate program officer no later than 3 years after all patient follow up is complete or 2 years after main manuscript publication of study results (whichever comes first). Dr. Smith will also include documentation and key study documents such as protocol, electronic case report forms, manuals of procedures, and applicable training materials to enable the use of prepared data sets by outside investigators. Data sets and associated documentation will be provided in the preferred electronic format. The prepared and submitted data set will include at minimum baseline, interim visit, procedural and intervention based data, and outcomes data.

Shared Documents
STUDY PROTOCOL

Locations